{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:39:17Z","timestamp":1725525557114},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T00:00:00Z","timestamp":1396569600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0094118","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T21:00:21Z","timestamp":1396645221000},"page":"e94118","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Expression of RAGE and HMGB1 in Thymic Epithelial Tumors, Thymic Hyperplasia and Regular Thymic Morphology"],"prefix":"10.1371","volume":"9","author":[{"given":"Bernhard","family":"Moser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Janik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Iris","family":"Schiefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonhard","family":"M\u00fcllauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Bekos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Scharrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mildner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferenc","family":"R\u00e9nyi-V\u00e1mos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik Jan","family":"Ankersmit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1378\/chest.128.4.2893","article-title":"Tumors of the mediastinum","volume":"128(4)","author":"BV Duwe","year":"2005","journal-title":"Chest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00595-005-3047-y","article-title":"Thymoma and thymic carcinoma: an update of the WHO Classification 2004","volume":"35(10)","author":"P Str\u00f6bel","year":"2005","journal-title":"Surg Today"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S1710","DOI":"10.1097\/JTO.0b013e31821e8cff","article-title":"The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms","volume":"6(7","author":"FC Detterbeck","year":"2011","journal-title":"J Thorac Oncol"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Moser B, Scharitzer M, Hacker S, Ankersmit J, Matilla JR, <etal>et al<\/etal>.. (2012) Thymomas and Thymic Carcinomas: Prognostic Factors and Multimodal Management. Thorac Cardiovasc Surg DOI: 10.1055\/s-0032-1322611","DOI":"10.1055\/s-0032-1322611"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5(10","author":"EA Engels","year":"2010","journal-title":"J Thorac Oncol"},{"key":"ref6","unstructured":"Castleman B (1955) Atlas of tumor pathology. Tumors of the thymus gland, fascicle 19. Armed Forces Institute of Pathology, Washington, DC"},{"key":"ref7","unstructured":"Rosai J, Levine GD (1976) Atlas of tumor pathology. Tumors of the thymus, Second series, fascicle 13. Armed Forces Institute of Pathology, Washington, DC"},{"key":"ref8","first-page":"797","article-title":"Unravelling the pathogenesis of myasthenia gravis, Nat. Rev","volume":"2(10)","author":"A Vincent","year":"2002","journal-title":"Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbrc.2012.02.121","article-title":"The receptor for advanced glycation endproducts and its ligands in patients with myasthenia gravis","volume":"420(1)","author":"B Moser","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mus.22103","article-title":"The thymus in myasthenia gravis: Site of &quot;innate autoimmunity&quot;?","volume":"44(4)","author":"P Cavalcante","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref11","first-page":"127","article-title":"Malignant thymoma: current status and future directions","volume":"26(2)","author":"PN Lara Jr","year":"2000","journal-title":"Cancer Treat Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1634\/theoncologist.6-3-239","article-title":"Thymoma: update for the new millennium","volume":"6(3)","author":"SB Johnson","year":"2001","journal-title":"Oncologist"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","article-title":"Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins","volume":"267(21)","author":"M Neeper","year":"1992","journal-title":"J Biol Chem 25"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"14987","DOI":"10.1016\/S0021-9258(18)42137-0","article-title":"Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface","volume":"267","author":"AM Schmidt","year":"1992","journal-title":"J. Biol. Chem"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Leclerc E, Sturchler E, Vetter SW. (2010) The S100B\/RAGE axis in Alzheimer&apos;s disease. Cardiovasc. Psychiatry Neurol 539581. doi: 10.1155\/2010\/539581.","DOI":"10.1155\/2010\/539581"},{"key":"ref16","first-page":"743","article-title":"S100A8\/A9: a mediator of severe asthma pathogenesis and morbidity? Can","volume":"87(10)","author":"AJ Halayko","year":"2009","journal-title":"J. Physiol. Pharmacol"},{"key":"ref17","first-page":"354","article-title":"Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases, Nature","volume":"405(6784)","author":"A Taguchi","year":"2000"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1172\/JCI118889","article-title":"The receptor for advanced glycation endproducts (RAGE) mediates the interaction of AGE-beta2 microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: implications for the pathogenesis of dialysis-related amyloidosis","volume":"98","author":"T Miyata","year":"1996","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nm831","article-title":"Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system","volume":"9","author":"SS Yan","year":"2003","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20040934","article-title":"RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB","volume":"201","author":"G Cataldegirmen","year":"2005","journal-title":"J Exp Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.4049\/jimmunol.179.12.8051","article-title":"Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo","volume":"179(12)","author":"B Moser","year":"2007","journal-title":"J Immunol 15"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-6143.2006.01617.x","article-title":"Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation","volume":"7(2)","author":"B Moser","year":"2007","journal-title":"Am J Transplant"},{"key":"ref23","first-page":"2756","article-title":"Alternative splicing of RAGE: roles in biology and disease, Front Biosci","volume":"1(17)","author":"AZ Kalea","year":"2011"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1158\/1078-0432.CCR-13-0495","article-title":"HMGB1 in Cancer: Good, Bad, or Both?","volume":"19(15)","author":"R Kang","year":"2013","journal-title":"Clin Cancer Res 1"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. (2010) HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28: 367\u201388. Review.","DOI":"10.1146\/annurev.immunol.021908.132603"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, <etal>et al<\/etal>.. (2009) RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 17;7: 17. Review.","DOI":"10.1186\/1479-5876-7-17"},{"key":"ref27","volume":"15(3)","unstructured":"Hiwatashi K, Ueno S, Abeyama K, Kubo F, Sakoda M, <etal>et al<\/etal>.. (2008) A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC. Ann Surg Oncol <volume>15(3)<\/volume>: : 9 23\u201333."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1084\/jem.20080136","article-title":"Inciting inflammation: the RAGE about tumor promotion","volume":"205(2)","author":"M Dougan","year":"2008","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1158\/0008-5472.CAN-10-2573","article-title":"Evidence That Serum Levels of the Soluble Receptor for Advanced Glycation End Products Are Inversely Associated with Pancreatic Cancer Risk: A Prospective Study","volume":"71","author":"L Jiao","year":"2011","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00432-011-1067-0","article-title":"Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma","volume":"138","author":"L Lin","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1158\/1055-9965.EPI-11-0066","article-title":"Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products, and Risk of Colorectal Cancer","volume":"20","author":"L Jiao","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1742-2094-8-32","article-title":"Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma","volume":"8","author":"M Tafani","year":"2011","journal-title":"Journal of Neuroinflammation"},{"key":"ref33","first-page":"823","article-title":"[Expression of RECK, RAGE and MMP-9 in nasopharyngeal carcinoma and its significance]","volume":"24(18)","author":"R Li","year":"2010","journal-title":"[Article in Chinese] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s12013-013-9515-x","article-title":"Immunohistochemical Expression of RAGE and Its Ligand (S100A9) in Cervical Lesions","volume":"66(3)","author":"X Zhu","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"ref35","first-page":"485","article-title":"Clinical significance of immunogenic cell death biomarker rage and early growth response 1 in human primary gastric adenocarcinoma","volume":"26(2)","author":"XC Xu","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e43734","DOI":"10.1371\/journal.pone.0043734","article-title":"RAGE genetic polymorphisms are associated with risk, chemotherapy response and prognosis in patients with advanced NSCLC","volume":"7(10)","author":"X Wang","year":"2012","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China","volume":"95(2)","author":"G Chen","year":"2002","journal-title":"Cancer"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1158\/0008-5472.CAN-11-2291","article-title":"p53\/HMGB1 complexes regulate autophagy and apoptosis","volume":"72(8)","author":"KM Livesey","year":"2012","journal-title":"Cancer Res 15"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00428-005-1210-x","article-title":"Expression of receptor for advanced glycation end products and HMGB1\/amphoterin in colorectal adenomas","volume":"446(4)","author":"T Sasahira","year":"2005","journal-title":"Virchows Arch"},{"key":"ref40","first-page":"445","article-title":"Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer","volume":"10(2)","author":"H Kuniyasu","year":"2003","journal-title":"Oncol Rep"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.healun.2007.05.019","article-title":"Incidence of malignancies in heart and\/or lung transplant recipients: a single-institution experience","volume":"26(8)","author":"S Roithmaier","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.1.5022.779","article-title":"Cancer; a biological approach. I. The processes of control","volume":"1(5022)","author":"M Burnet","year":"1957","journal-title":"Br Med J 6"},{"key":"ref43","first-page":"329","article-title":"On immunosurveillance in human cancer","volume":"55(3-4)","author":"L Thomas","year":"1982","journal-title":"Yale J Biol Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population","volume":"356(9244)","author":"K Imai","year":"2000","journal-title":"Lancet 25"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.athoracsur.2011.05.089","article-title":"Thymomas and extrathymic cancers","volume":"93(3)","author":"B Weksler","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thorsurg.2010.08.002","article-title":"Published guidelines for management of thymoma","volume":"21(1)","author":"Y Fujii","year":"2011","journal-title":"Thorac Surg Clin"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/intimm\/4.6.707","article-title":"The thymic compartment responsible for positive selection of CD4+ T cells","volume":"4(6)","author":"D Cosgrove","year":"1992","journal-title":"Int Immunol"},{"key":"ref48","first-page":"614","article-title":"The plasma level of soluble receptor for advanced glycation end products is decreased in patients with systemic lupus erythematosus","volume":"75(6)","author":"CY Ma","year":"2012","journal-title":"Scand J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2796.2011.02432.x","article-title":"High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus","volume":"270(4)","author":"V Urbonaviciute","year":"2011","journal-title":"J Intern Med"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Pisetsky DS, Erlandsson-Harris H, Andersson U. (2008) High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther 10(3): 209. Review.","DOI":"10.1186\/ar2440"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"R817","DOI":"10.1186\/ar1749","article-title":"Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control","volume":"7(4)","author":"R Pullerits","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.gene.6363861","article-title":"RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response","volume":"3(3)","author":"MA Hofmann","year":"2002","journal-title":"Genes Immun"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nature03886","article-title":"Hassall&apos;s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus","volume":"436(7054)","author":"N Watanabe","year":"2005","journal-title":"Nature"},{"key":"ref54","first-page":"1147","article-title":"Regulation of cytokine production in the human thymus: epidermal growth factor and transforming growth factor alpha regulate mRNA levels of interleukin 1 alpha (IL-1 alpha), IL-1 beta, and IL-6 in human thymic epithelial cells at a post-transcriptional level","volume":"174(5)","author":"PT Le","year":"1991","journal-title":"J Exp Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.167.4.1935","article-title":"Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis","volume":"167(4)","author":"GP Sims","year":"2001","journal-title":"J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/eji.200939914","article-title":"Ectopic GC in the thymus of myasthenia gravis patients show characteristics of normal GC","volume":"40(4)","author":"NS Zuckerman","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1093\/nar\/gks1461","article-title":"Cooperative recruitment of HMGB1 during V(D)J recombination through interactions with RAG1 and DNA","volume":"41(5)","author":"AJ Little","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"31314","DOI":"10.1074\/jbc.M503063200","article-title":"Both high mobility group (HMG)-boxes and the acidic tail of HMGB1 regulate recombination-activating gene (RAG)-mediated recombination signal synapsis and cleavage in vitro","volume":"280(35)","author":"S Bergeron","year":"2005","journal-title":"J Biol Chem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000329496","article-title":"Thymic involution: where endocrinology meets immunology","volume":"18(5)","author":"AE Calder","year":"2011","journal-title":"Neuroimmunomodulation"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jneuroim.2008.05.020","article-title":"Reflections on the &quot;intrathymic pathogenesis&quot; of myasthenia gravis","volume":"201\u2013202","author":"R Hohlfeld","year":"2008","journal-title":"J Neuroimmunol"},{"key":"ref61","first-page":"465","article-title":"Studies in myasthenia gravis: effects of thymectomy. Results on 185 patients with nonthymomatous and thymomatous myasthenia gravis, 1941\u20131969","volume":"50(4)","author":"AE Papatestas","year":"1971","journal-title":"Am J Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12(9)","author":"A Marx","year":"2013","journal-title":"Autoimmun Rev"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00441-006-0202-8","article-title":"Development and maturation of thymic dendritic cells during human ontogeny","volume":"325(3)","author":"AS Savchenko","year":"2006","journal-title":"Cell Tissue Res"},{"key":"ref64","first-page":"402","article-title":"The normal human newborns thymus","volume":"114(7)","author":"V Jablonska-Mestanova","year":"2013","journal-title":"Bratisl Lek Listy"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.aanat.2006.01.012","article-title":"Structural heterogeneity and immunohistochemical profile of Hassall corpuscles in normal human thymus","volume":"188(4)","author":"M Raica","year":"2006","journal-title":"Ann Anat"},{"key":"ref66","first-page":"101","article-title":"Involution of the thymus: a possible diagnostic pitfall","volume":"48(2)","author":"M Raica","year":"2007","journal-title":"Rom J Morphol Embryol"},{"key":"ref67","first-page":"985","article-title":"Immunohistological characterization of thymic dendritic cells","volume":"26(6)","author":"M Raica","year":"2012","journal-title":"In Vivo"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/00000478-199012000-00006","article-title":"An immunohistochemical study of thymic epithelial tumors. III. The distribution of interdigitating reticulum cells and S-100 beta-positive small lymphocytes","volume":"14(12)","author":"K Kondo","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"ref69","unstructured":"Gao K, Wang YC, Ma XH, Li T, Wu Z, <etal>et al<\/etal>.. (2008) [Expression of Toll-like receptors in thymus of myasthenia gravis patients]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25(3): 311\u20134. [Article in Chinese["},{"key":"ref70","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11748-012-0160-x","article-title":"Immunohistochemical analysis of thymic carcinoma focusing on the possibility of molecular targeted and hormonal therapies","volume":"60(12)","author":"M Omatsu","year":"2012","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1189\/jlb.0409230","article-title":"RAGE: therapeutic target and biomarker of the inflammatory response\u2014the evidence mounts","volume":"86(3)","author":"R Ramasamy","year":"2009","journal-title":"J Leukoc Biol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/JTO.0b013e3181c59224","article-title":"International thymic malignancy interest group","volume":"5(1)","author":"F Detterbeck","year":"2010","journal-title":"J Thorac Oncol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/JTO.0b013e318207cd74","article-title":"European Society of Thoracic Surgeons Thymic Questionnaire Working Group. Management of thymic tumors: a survey of current practice among members of the European Society of Thoracic Surgeons","volume":"6(3)","author":"E Ruffini","year":"2011","journal-title":"J Thorac Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0094118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:30:46Z","timestamp":1648758646000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0094118"}},"subtitle":[],"editor":[{"given":"Barry I.","family":"Hudson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,4]]},"references-count":73,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0094118","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,4]]}}}